HighlightsSales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Highlights Sales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Palantir also gave stronger guidance than Wall Street anticipated. Management estimates that first-quarter revenue will ...

Tariffs impart a modest stagflationary shock to an economy. The U.S. economy entered 2025 with a fair amount of momentum, but ...

Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...

Retired-worker benefits can hit a psychologically important level next year, but seniors are still likely to get the short ...

as amended (the "Company"), today is pleased to announce the declaration of distributions on shares of the Company’s common and preferred stock for the first fiscal quarter 2026 (second calendar ...

The economic expansion is expected to be driven by a gradual recovery in oil production and robust non-oil sector growth ...

Lesaka Technologies faces a slump despite growth execution and guidance updates. Read here for an investment analysis of LSAK ...

Magna International (MGA) provided a full-year revenue outlook that fell short of Wall Street's expectations amid likely weakness in vehicle production, even though the Canadian auto parts supplier ...

As a result of these developments, Bank of America now forecasts the NZD to end the year at 0.62, revised from the previous ...

Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory approval during the first quarter of next year, slightly later than its previous ...